NewsFirst Molecular Blueprint of Neuropeptide Receptor Universität Leipzig | February 11, 2021 The blueprint will enable the development of tailor-made drugs to treat epilepsy or cardiovascular diseases
NewsMore Than 200 Genetic Factors Cause Heart ArrhythmiasQueen Mary University of London | May 25, 2020 Research results could one day lead to advanced screening methods to discern who is at greatest risk of developing disease
Industry NewsHamilton and IMCS Jointly Develop affinityPure™ STAR Assay Ready Workstation to Aid Coronavirus ResearchHamilton Robotics | April 28, 2020 Robust workflow solution enables rapid, high throughput protein affinity purifications
Product NewsGlobal COVID-19 Clinical Trial Tracker Launched by CytelCytel | April 8, 2020 Live dashboard offers an overview of all the trials taking place in the international effort to tackle the pandemic
NewsTurbo Chip for Drug DevelopmentKarlsruhe Institute of Technology | July 15, 2019 KIT scientists develop process that facilitates and accelerates chemical synthesis and biological screening by combining all steps on a chip
MultimediaDrug Discovery: From Lab to PharmacyLab Manager | November 7, 2018 The journey from lead discovery to final approval can be long and challenging